in conversation with AIM
summary
A privacy-aware system measures temperature variations across the chest and feeds them into an AI engine to flag potential breast abnormalities; clinical validation shows performance better than standard of care. The solution is deployed with about 20 partners across nine cities and has screened over 6,000 patients so far. Discussion covers the validation pathway, investor conversations (80–100 pitches before traction), adoption hurdles with clinicians and hospitals, and steps toward product–market fit.
AI-written summary · about
chapters (6)
- 0:00Intro
- 1:00How was your experience founding a company and how has the ecosystem helped you?
- 2:49What is your advice for women CEOs and founders?
- 4:44What is your advice to women who are making a transition from corporate to an entrepreneurial career?
- 6:14What policy changes can help women in this industry?
- 7:29How was your experience at the Rising 2019?
related talks
12mFrom Vibe-Coding to Fundraising: How AI Founders Stand Out in a Noisy Market
20mAI Adoption at Scale
20mWhy Adoption Matters - GenAI Journey of a German Insurance Company
01h 13mFeminist perspectives on privacy and data protection.
16mKey Points and Lessons Learned in AI Projects in Mechanical Engineering
01h 27mPanel - Women in Data Science
21mApplied AI & Data Analytics
11mInterview